SI-BONE, Inc.

NASDAQ:SIBN

Medical - Devices

Healthcare
$23.54 +3.45%

+$0.53 today

Market cap
$1.06B
Beta
0.70
P/E (TTM)
-41.4
EPS (TTM)
-$0.38
52W Low $11.48High $21.89

Volume 1.12M

Average 0.68M

SIBN Accounts Payables

Cash effect of the change in amounts owed to suppliers; growing payables preserve cash.

SI-BONE, Inc.NASDAQ: SIBN

Accounts Payables · Q1 FY2026 · quarter ended Mar 2026

Accounts payables growth accelerates

Q1 FY2026 accounts payables of $2.1M rose 120.4% year over year, ahead of the -239.6% change in trailing-twelve-month accounts payables.

Context

  • Accounts payables amounted to 0.9% of revenue in FY2025, down 0.2 pp from a year earlier.
  • Accounts payables increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +120.4% holds above the trailing-twelve-month pace of -239.6%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$2.1M+169.7% QoQ
Last fiscal yearDec 2025
-$1.76M-194.7% YoY
LTMMar 2026
-$617K-239.6% YoY
Accounts Payables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+120.4%——
1 year-194.7%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Accounts Payables history

USD · from the cash flow

Latest · FY2025
(1.76M) USD
Year-over-year change
-194.7%

Accounts Payables vs competitors

How SIBN compares with its peers on the latest reported figures

  • SIBN's LTM Mar 2026 accounts payables of $617K is the 5th largest of the 6 companies compared; the peer median is $8.05M.
  • Its year-over-year change of -239.6% is the lowest of 5, against a peer median of +177.2%.
  • Accounts payables amounts to 0.3% of revenue for SIBN, versus a peer median of 0.6%.
SIBN Competitors Peer median
Accounts Payables for SIBN and competitors
Company Period LTM YoY 3-year CAGR% of revenue
SYKStryker CorporationLTM Jun 2026$236M +84.4%-31.3%0.9%
GMEDGlobus Medical, Inc.LTM Jun 2026$17.96M +790.5%-16.2%0.6%
CNMDCONMED CorporationLTM Mar 2026$8.05M +243.6%—0.6%
ATECAlphatec Holdings, Inc.LTM Mar 2026$963K +110.7%—0.1%
SIBNSI-BONE, Inc.LTM Mar 2026$617K -239.6%—0.3%
SNNSmith & Nephew plcFY2025$0 ——0.0%
Peer median (excluding SIBN) $8.05M+177.2%-23.7%0.6%

Competitors are the stored peer set for SIBN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(56.57M)(61.26M)(43.34M)(30.91M)(18.9M)
Depreciation & Amortization2.09M3.45M5.43M4.38M2.72M
Deferred Income Tax3.56M0000
Stock-Based Compensation16.87M23.06M24.06M25.87M25.52M
Change in Working Capital(5.76M)(7.64M)(4.83M)(10.12M)(14.33M)
Accounts Receivables(569K)(6.48M)(2.12M)(5.84M)(3.03M)
Inventory(5.78M)(5.71M)(4.72M)(8.05M)(8.68M)
Accounts Payables(532K)2.53M(1.12M)1.86M(1.76M)
Other Working Capital1.13M2.02M3.13M1.91M(851K)
Other Non-Cash Items288K730K(29K)(1.64M)4.31M
Operating Cash Flow(39.53M)(41.66M)(18.71M)(12.43M)(675K)
Capital Expenditures(6.39M)(9.51M)(7.8M)(10.5M)(8.41M)
Acquisitions (Net)(57.97M)0000
Purchases of Investments(102.02M)(119.51M)(189.5M)(205.38M)(192.53M)
Sales of Investments159.99M126.2M137.5M228.5M205.1M
Other Investing Activities57.97M0000
Investing Cash Flow51.58M(2.82M)(59.8M)12.62M4.16M
Debt Repayment(6.62M)0725K(46K)0
Common Stock Issued4.91M2.2M83.67M2.72M3.38M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities006.54M(720K)0
Financing Cash Flow(1.71M)2.2M90.93M1.96M3.38M
Effect of Forex Changes(498K)(429K)132K(479K)431K
Net Change in Cash9.84M(42.7M)12.55M1.68M7.29M
Free Cash Flow(45.92M)(51.16M)(26.51M)(22.92M)(9.09M)

SI-BONE, Inc.

NASDAQ:SIBN

Intrinsic Alpha fair value

Locked

Current Price

$23.54

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.